CEACAM5 and laryngotracheoesophageal cleft: ,3 Several immunoassay-based serum biomarkers, including cytokeratin 19-fragments (Cyfra 21-1),4 human epididymis protein 4 (HE4),5,6 and carcinoembryonic antigen (CEA),7 have been proposed for the diagnosis of LC.